These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16714924)

  • 41. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum A toxin injection as a treatment for blepharospasm.
    Scott AB; Kennedy RA; Stubbs HA
    Arch Ophthalmol; 1985 Mar; 103(3):347-50. PubMed ID: 3977705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm.
    Jankovic J
    Eur J Neurol; 2009 Dec; 16 Suppl 2():14-8. PubMed ID: 20002742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm: a double-blind, controlled study.
    Mezaki T; Kaji R; Kohara N; Fujii H; Katayama M; Shimizu T; Kimura J; Brin MF
    Neurology; 1995 Mar; 45(3 Pt 1):506-8. PubMed ID: 7898706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm.
    Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of botulinum toxin in the treatment of essential blepharospasm].
    Safran AB
    Schweiz Rundsch Med Prax; 1990 Nov; 79(48):1512-4. PubMed ID: 2255835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of blepharospasm with botulinum toxin.
    Tsoy EA; Buckley EG; Dutton JJ
    Am J Ophthalmol; 1985 Feb; 99(2):176-9. PubMed ID: 3970122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
    Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
    Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye.
    Horwath-Winter J; Bergloeff J; Floegel I; Haller-Schober EM; Schmut O
    Br J Ophthalmol; 2003 Jan; 87(1):54-6. PubMed ID: 12488263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Safety and Efficacy of Botox and Neuronox in the Management of Benign Essential Blepharospasm: A Split-face Study.
    Sane S; Ali MJ; Naik MN
    Korean J Ophthalmol; 2019 Oct; 33(5):430-435. PubMed ID: 31612653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of blepharospasm with botulinum toxin].
    Pikielny RT; Micheli FE; Fernández Pardal MM; Casas Parera I; Giannaula RJ; Gatto M
    Medicina (B Aires); 1990; 50(2):129-34. PubMed ID: 2101846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beneficial effect of botulinum A toxin in blepharospasm: 16 months' experience with 16 cases.
    Maurri S; Brogelli S; Alfieri G; Barontini F
    Ital J Neurol Sci; 1988 Aug; 9(4):337-44. PubMed ID: 3220708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of blepharospasm, hemifacial spasm and strabismus with botulinum a toxin.
    Dai Z; Wang YC
    Chin Med J (Engl); 1992 Jun; 105(6):476-80. PubMed ID: 1451548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term therapy of benign essential blepharospasm and facial hemispasm with botulinum toxin A: retrospective assessment of the clinical and quality of life impact in patients treated for more than 15 years.
    Streitová H; Bareš M
    Acta Neurol Belg; 2014 Dec; 114(4):285-91. PubMed ID: 24604684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment.
    Quagliato EM; Carelli EF; Viana MA
    Clin Neuropharmacol; 2010; 33(1):27-31. PubMed ID: 20124784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Botulinum toxin in the management of blepharospasm.
    Dutton JJ; Buckley EG
    Arch Neurol; 1986 Apr; 43(4):380-2. PubMed ID: 3954621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin A in clinical medicine.
    Elston JS
    J Physiol (Paris); 1990; 84(4):285-9. PubMed ID: 2079665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.